BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Report Library

All Reports
Datamonitor Healthcare I&I: Glaucoma Market Spotlight

May 15, 2020

Glaucoma is not just one eye disease, but a group of eye conditions resulting in optic nerve damage, which may cause loss of vision and blindness. In glaucoma, damage to the optic nerve is usually caused by elevated intraocular pressure (IOP). IOP rises when passages that allow fluid to drain become blocked. However, one person may develop nerve damage at a relatively low pressure, while another person may have high pressure for years and yet never develop damage. Although IOP is clearly a risk factor, other risk factors are present. In the early stages of the disease, there may be no symptoms. It is estimated that 50% of the people who have glaucoma are not being treated as they are not aware that they have the disease.

This Datamonitor Healthcare report contains a Market Spotlight module.
Indications Covered: Glaucoma / Ocular Hypertension (Ophthalmology)
Back to the top Back to the top